- Home
- IMMX vs PETS Comparison
IMMX vs PETS Comparison
Compare IMMX & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- PETS
- Stock Information
- Founded
- IMMX 2014
- PETS 1996
- Country
- IMMX United States
- PETS United States
- Employees
- IMMX N/A
- PETS N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- IMMX Health Care
- PETS Consumer Staples
- Exchange
- IMMX Nasdaq
- PETS Nasdaq
- Market Cap
- IMMX 65.5M
- PETS 53.7M
- IPO Year
- IMMX 2021
- PETS N/A
- Fundamental
- Price
- IMMX $2.47
- PETS $2.54
- Analyst Decision
- IMMX Strong Buy
- PETS Sell
- Analyst Count
- IMMX 1
- PETS 1
- Target Price
- IMMX $8.00
- PETS $3.20
- AVG Volume (30 Days)
- IMMX 221.4K
- PETS 113.6K
- Earning Date
- IMMX 11-11-2025
- PETS 11-05-2025
- Dividend Yield
- IMMX N/A
- PETS N/A
- EPS Growth
- IMMX N/A
- PETS N/A
- EPS
- IMMX N/A
- PETS 0.02
- Revenue
- IMMX N/A
- PETS $247,010,000.00
- Revenue This Year
- IMMX N/A
- PETS N/A
- Revenue Next Year
- IMMX N/A
- PETS N/A
- P/E Ratio
- IMMX N/A
- PETS $148.85
- Revenue Growth
- IMMX N/A
- PETS N/A
- 52 Week Low
- IMMX $1.34
- PETS $2.45
- 52 Week High
- IMMX $3.20
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- IMMX 67.32
- PETS 36.72
- Support Level
- IMMX $1.94
- PETS $2.52
- Resistance Level
- IMMX $2.13
- PETS $2.64
- Average True Range (ATR)
- IMMX 0.16
- PETS 0.09
- MACD
- IMMX 0.05
- PETS 0.01
- Stochastic Oscillator
- IMMX 99.45
- PETS 23.75
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.